172 related articles for article (PubMed ID: 23470153)
1. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
Gómez-Almaguer D; Tarín-Arzaga L; Moreno-Jaime B; Jaime-Pérez JC; Ceballos-López AA; Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Sánchez-Cárdenas M
Eur J Haematol; 2013 Jun; 90(6):494-500. PubMed ID: 23470153
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
[TBL] [Abstract][Full Text] [Related]
3. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
Ghanima W; Khelif A; Waage A; Michel M; Tjønnfjord GE; Romdhan NB; Kahrs J; Darne B; Holme PA;
Lancet; 2015 Apr; 385(9978):1653-61. PubMed ID: 25662413
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
Zaja F; Vianelli N; Volpetti S; Battista ML; Defina M; Palmieri S; Bocchia M; Medeot M; De Luca S; Ferrara F; Isola M; Baccarani M; Fanin R
Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].
Cui ZG; Wei Y; Hou M; Zhao HG; Wang HY
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):401-3. PubMed ID: 21624223
[TBL] [Abstract][Full Text] [Related]
7. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
Zhu YC; Wang W; Zhou YH; Wang XM; Wang X; Wang YL; Sun GZ; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].
Wang L; Guo CS; Hou M; Li LZ; Zhang CQ; Chen F; Qin P; Peng J; He WD; Chu XX
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):274-6. PubMed ID: 17637261
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
Mahévas M; Ebbo M; Audia S; Bonnotte B; Schleinitz N; Durand JM; Chiche L; Khellaf M; Bierling P; Roudot-Thoraval F; Godeau B; Michel M
Am J Hematol; 2013 Oct; 88(10):858-61. PubMed ID: 23798363
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
D'Arena G; Capalbo S; Laurenti L; Del Poeta G; Nunziata G; Deaglio S; Spinosa G; Tarnani M; De Padua L; Califano C; Ferrara F; Cascavilla N
Eur J Haematol; 2010 Dec; 85(6):502-7. PubMed ID: 20846302
[TBL] [Abstract][Full Text] [Related]
12. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Dubbeld P; van der Heul C; Hillen HF
Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
[TBL] [Abstract][Full Text] [Related]
14. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.
Li Z; Mou W; Lu G; Cao J; He X; Pan X; Xu K
Int J Hematol; 2011 Jan; 93(1):91-8. PubMed ID: 21188563
[TBL] [Abstract][Full Text] [Related]
15. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
16. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R
Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
[TBL] [Abstract][Full Text] [Related]
17. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia.
Gudbrandsdottir S; Birgens HS; Frederiksen H; Jensen BA; Jensen MK; Kjeldsen L; Klausen TW; Larsen H; Mourits-Andersen HT; Nielsen CH; Nielsen OJ; Plesner T; Pulczynski S; Rasmussen IH; Rønnov-Jessen D; Hasselbalch HC
Blood; 2013 Mar; 121(11):1976-81. PubMed ID: 23293082
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
[TBL] [Abstract][Full Text] [Related]
19. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
Oved JH; Lee CSY; Bussel JB
J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
